NUVASIVE INC 4

4 · NUVASIVE INC · Filed Mar 10, 2015

Form 4

Period: 2015-03-06

DirectorCEO and Chairman

Transactions

Tax Payment
Common Stock
2015-03-06$44.92/sh−13,437$603,590→ 333,680 total
Sale
Common Stock
2015-03-09$44.81/sh−5,313$238,102→ 328,367 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2015-03-06+18,750→ 0 total
Exercise: $18.31Exp: 2016-01-03→ Common Stock (18,750 underlying)
Exercise/Conversion
Common Stock
2015-03-06$18.31/sh+18,750$343,313→ 347,117 total

Footnotes (5)

[F1]Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive or purchase (as appropriate) shares pursuant to previously disclosed Company equity awards.
[F2]Payment of exercise price and tax liability by Issuer's withholding of shares incident to the respective option exercise.
[F3]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on November 15, 2014, which is intended to comply with Rule 10b5-1.
[F4]Weighted average from 27 transactions with prices ranging from $44.560 to $45.050. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.
[F5]The option, representing a right to purchase a total of 244,539 shares, became exercisable as follows: 25% of the shares vested on January 3, 2007; the remaining shares vested monthly thereafter so that all shares were fully vested as of January 3, 2010, subject to continued employment through each vesting period.

Documents

1 file